JPMorgan raised the firm’s price target on Septerna (SEPN) to $38 from $34 and keeps an Overweight rating on the shares. The firm updated the company’s model post the Q4 report.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SEPN:
- Septerna, Inc. (SEPN) Q4 Earnings Cheat Sheet
- Septerna price target raised to $35 from $34 at Truist
- Septerna files automatic mixed securities shelf
- Septerna: Novo-Backed GPCR Platform and Best-in-Class Potential for Oral MRGPRX2 Inhibitor SEP-631 Support Buy Rating
- Septerna reports Q4 EPS (24c), consensus (22c)